HBR IdeaCast

The CEO of Merck on Race, Leadership, and High Drug Prices

02.19.2018 - By Harvard Business ReviewPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Kenneth Frazier, the CEO of the pharmaceutical company known as MSD outside of North America, discusses his upbringing and how it influences his leadership as chief executive. He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices.

More episodes from HBR IdeaCast